Dow Up 0.07% Nasdaq Up 0.61%

NPS Pharmaceuticals, Inc. (NPSP)

-NasdaqGS
33.96 Up 0.93(2.82%) 4:00PM EST
|After Hours : 33.96 0.00 (0.00%) 4:36PM EST
Prev Close:33.03
Open:32.99
Bid:33.91 x 100
Ask:34.00 x 200
1y Target Est:37.64
Beta:-0.01
Earnings Date:Feb 16 - Feb 20 (Est.)
Day's Range:32.80 - 34.00
52wk Range:22.11 - 39.68
Volume:715,057
Avg Vol (3m):2,159,420
Market Cap:3.63B
P/E (ttm):3,396.00
EPS (ttm):0.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NPSPUp 2.82%3.63B
ABTUp 0.20%66.63B
BIIBDown 0.16%72.01B

Key Statistics

Forward P/E (1 yr):39.03
P/S (ttm):16.66
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.02
Quarterly EPS Est (Dec-14) :0.04
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-14.52

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NPS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapeutic products in the United States. Its lead product is Gattex for the treatment of adult patients with short bowel syndrome (SBS) who are dependent on pa... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback